These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11121230)

  • 1. RNA damage and inhibition of neoplastic endothelial cell growth: effects of human and amphibian ribonucleases.
    Newton DL; Kaur G; Rhim JS; Sausville EA; Rybak SM
    Radiat Res; 2001 Jan; 155(1 Pt 2):171-174. PubMed ID: 11121230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential behavior of VEGF receptor expression and response to TNP-470 in two immortalized human endothelial cell lines.
    Seki M; Toi M; Kobayashi K; Shitara K; Umezawa K; Seon BK; Kan M; Rhim JS
    Int J Oncol; 2000 Sep; 17(3):525-33. PubMed ID: 10938394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells.
    Yeh CH; Peng HC; Yang RS; Huang TF
    Mol Pharmacol; 2001 May; 59(5):1333-42. PubMed ID: 11306719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.
    Boix E; Wu Y; Vasandani VM; Saxena SK; Ardelt W; Ladner J; Youle RJ
    J Mol Biol; 1996 Apr; 257(5):992-1007. PubMed ID: 8632481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity of an antitumor ribonuclease to Purkinje neurons.
    Newton DL; Walbridge S; Mikulski SM; Ardelt W; Shogen K; Ackerman SJ; Rybak SM; Youle RJ
    J Neurosci; 1994 Feb; 14(2):538-44. PubMed ID: 8301353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity.
    Wu Y; Mikulski SM; Ardelt W; Rybak SM; Youle RJ
    J Biol Chem; 1993 May; 268(14):10686-93. PubMed ID: 8486718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro.
    Chen HH; Zhou HJ; Fang X
    Pharmacol Res; 2003 Sep; 48(3):231-6. PubMed ID: 12860439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
    Chuang CH; Liu CH; Lu TJ; Hu ML
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus.
    Domachowske JB; Dyer KD; Bonville CA; Rosenberg HF
    J Infect Dis; 1998 Jun; 177(6):1458-64. PubMed ID: 9607820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor.
    Morais C; Gobe G; Johnson DW; Healy H
    Angiogenesis; 2009; 12(4):365-79. PubMed ID: 19882112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
    He GA; Luo JX; Zhang TY; Hu ZS; Wang FY
    Biochem Biophys Res Commun; 2004 May; 318(2):354-60. PubMed ID: 15120609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity.
    Domachowske JB; Dyer KD; Adams AG; Leto TL; Rosenberg HF
    Nucleic Acids Res; 1998 Jul; 26(14):3358-63. PubMed ID: 9649619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
    Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
    Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.
    Kumar CC; Malkowski M; Yin Z; Tanghetti E; Yaremko B; Nechuta T; Varner J; Liu M; Smith EM; Neustadt B; Presta M; Armstrong L
    Cancer Res; 2001 Mar; 61(5):2232-8. PubMed ID: 11280792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A natural anti-inflammatory enone fatty acid inhibits angiogenesis by attenuating nuclear factor-κB signaling in vascular endothelial cells.
    Furuno A; Watari K; Nakamura M; Fukunaga Y; Jung JH; Ono M
    Int J Oncol; 2011 Feb; 38(2):493-501. PubMed ID: 21132269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
    Reinmuth N; Liu W; Ahmad SA; Fan F; Stoeltzing O; Parikh AA; Bucana CD; Gallick GE; Nickols MA; Westlin WF; Ellis LM
    Cancer Res; 2003 May; 63(9):2079-87. PubMed ID: 12727823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668.
    Zhang H; Issekutz AC
    Am J Pathol; 2002 Jun; 160(6):2219-30. PubMed ID: 12057924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells.
    Raffaella R; Gioia D; De Andrea M; Cappello P; Giovarelli M; Marconi P; Manservigi R; Gariglio M; Landolfo S
    Exp Cell Res; 2004 Feb; 293(2):331-45. PubMed ID: 14729471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.